The UMass Chan Medical School in Worcester announced Thursday it received a $35 million gift that aims to advance research to ...

A team of researchers from the Sant Pau Research Institute (IR Sant Pau) has published a study in the Journal of ...

Fifteen U.S. nonprofit organizations formed a new ALS group, ALS United, to help address the needs of people living with ALS.

ALS is a progressive neurodegenerative disease that currently has no cure. Commonly known as Lou Gehrig’s disease, ALS ...

AI-generated voice clones are bringing back the voices of people with MND, allowing some to communicate, connect, and even ...

A new UCLA Health study has discovered in mouse models that genes associated with repairing mismatched DNA are critical in eliciting damages to neurons that are most vulnerable in Huntington's disease ...

Tiziana Life Sciences, Ltd. (Nasdaq: TLSA) (“Tiziana” or the “Company”), a biotechnology company developing breakthrough immunomodulation therapies with its lead development candidate, intranasal ...

The candidate in question is VY9323, an AAV gene therapy combining a highly potent pri-miRNA against superoxide dismutase 1 ...

LEXINGTON, Mass. - Voyager Therapeutics, Inc. (NASDAQ:VYGR), a biotechnology firm focused on neurogenetic medicines with a market capitalization of $290 million, announced today it is reassessing its ...

Company to assess alternate payloads; no changes planned to novel capsid component - - Resulting shift of timeline and costs extends cash ...

ZEPHYRHILLS — Former Zephyrhills High football coach Tom Fisher, who spent the better part of two decades carving highly ...

"The Miami Project and the University of Miami are renowned for their pioneering research in neural interfaces for the treatment of debilitating neurological conditions," Neuralink co-founder and COO ...